Signup Crypto ETF Stocks News

Kalaris Announces Closing of Merger with AlloVir

Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative diseases of the retina ...

Source: www.globenewswire.com
March 18, 2025 | 20:21:00
Category: News

Micron Innovates From the Data Center to the Edge With NVIDIA

Micron HBM3E 12H and LPDDR5X-based SOCAMM solutions designed to unlock full potential of AI platforms Micron HBM3E 12H and LPDDR5X-based SOCAMM solutions designed to unlock full potential of AI platforms ...

Source: www.globenewswire.com
March 18, 2025 | 20:23:00
Category: News

Silexion Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Significant progress in preclinical pipeline targeting KRAS-driven solid tumor cancers with systemic administration demonstrating robust anti-tumor and anti-metastasis activity in orthotopic mouse models. Recent funding strengthens the company's ability to deliver long term value Significant ...

Source: www.globenewswire.com
March 18, 2025 | 20:29:00
Category: News

How Walmart- Klarna Deal Impacts Affirm? Goldman Sachs Analyst Weighs In - Affirm Holdings ( NASDAQ:AFRM )

Affirm loses exclusive Walmart loan partnership to Klarna. Goldman Sachs lowers Affirm's price target following Walmart shift. Join Nic Chahine live on Wednesday, March 19, at 6 PM ET for a step-by-step breakdown of how to to capitalize on post-Fed volatility and manage risk in this fast-moving ...

Source: www.benzinga.com
March 18, 2025 | 18:20:05
Category: News

Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst - Alpha Cognition ( NASDAQ:ACOG )

HC Wainwright initiated coverage on Alpha Cognition with a Buy rating and a $20 price target. Analyst projects Zunveyl could reach $540M in peak U.S. sales by the late 2030s.

Source: www.benzinga.com
March 18, 2025 | 18:22:58
Category: News

JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre - Apellis Pharmaceuticals ( NASDAQ:APLS )

Apellis' Q4 Syfovre sales reached $167.8 million, with 94,000 doses delivered to physician practices. Survey results point to steadier growth for Syfovre/branded geographic atrophy products over the next 12 months.

Source: www.benzinga.com
March 18, 2025 | 18:24:41
Category: News

Ethereum price in 'cursed' downtrend which could continue well into 2025 - Analyst

Ethereum's native token, Ether ( ETH ) , has ventured into oversold territory multiple times against Bitcoin ( BTC ) in recent months, but the altcoin has yet to show any signs of finding a price bottom. The trading situation is actually quite similar to a previous scenario, and ETH's market ...

Source: cointelegraph.com
March 18, 2025 | 18:26:00
Category: News

BofA Securities Analyst Projects Millrose Spin-Off To Weigh On Lennar's Earnings, Cuts Price Target - Lennar ( NYSE:LEN )

BofA analyst cuts Lennar's price forecast to $130, citing weak housing market and Millrose spin-off impact. Analyst expects Millrose to create net income and margin headwinds, projecting a $942M free cash flow drag in 2025.

Source: www.benzinga.com
March 18, 2025 | 18:26:33
Category: News

BitClout Founder Dodges Fraud Charge as Justice Department Scraps Case

The Department of Justice has dropped its case against the founder of crypto social network BitClout, following the SEC's earlier move.

Source: decrypt.co
March 18, 2025 | 18:29:01
Category: News

Binance CEO reiterates denial of Trump family deal talks

Binance CEO Richard Teng denied reports that Binance.US was in deal talks with entities affiliated with US President Donald Trump during a March 18 panel at Blockworks' 2025 Digital Asset Summit in New York.Teng's statement reiterated the position taken by Binance's founder, Changpeng "CZ" Zhao, ...

Source: cointelegraph.com
March 18, 2025 | 18:29:18
Category: News

© Natavest 2025 - 2026